Ceryvyn Therapeutics Limited (ASX:CYV)
Australia · Delayed Price · Currency is AUD 0.0100
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST
Ceryvyn Therapeutics Market Cap
Ceryvyn Therapeutics has a market cap or net worth of 13.68 million as of September 17, 2026. Its market cap has decreased by -98.15% in one year.
Market Cap
13.68M
Enterprise Value
-16.34M
Revenue
1.00K
Ranking
n/a
PE Ratio
0.04
Stock Price
0.01
ChartMarket Cap Chart
Since May 13, 1996, Ceryvyn Therapeutics's market cap has decreased from 39.30M to 13.68M, a decrease of -65.19%. That is a compound annual growth rate of -3.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 13.68M | -98.63% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 20.58M |
| EZZ Life Science Holdings | 19.53M |
| Argenica Therapeutics | 19.27M |
| Algorae Pharmaceuticals | 18.25M |
| Neurotech International | 16.53M |
| Immuron | 14.85M |
| Cambium Bio | 14.57M |
| ReNerve | 12.23M |